---
permalink: /publications/
title: "Peer-reviewed work"
---

18. “Rational Design, Synthesis, and Mechanism of (3S,4R)-3-Amino-4-(difluoromethyl)cyclopent-1-ene-1-carboxylic Acid Employing a Second Deprotonation Strategy for Selectivity of Human Ornithine Aminotransferase over GABA Aminotransferase”
Zhu W, Butrin A, Melani R, **Doubleday PF**, Ferreira G, Tavares, Maurício T, Habeeb MT; Beaupre B, Kelleher NL, Moran G, Liu, D, Silverman RB (in review, JACS)

17. "Extensive regulation of enzyme activity by phosphorylation in Escherichia coli" (Nat Com; PMID: 34561442).
Schastnaya E, Nakic ZR, Gruber CH, **Doubleday PF**, Krishnan A, Johns NI, Park J, Wang HH, Sauer U.

16. "Oncogenic KRAS creates an aspartate metabolism signature in colorectal cancer cells" (FEBS; PMID: 34227245). **Doubleday PF**, Fornelli L, Ntia I, Kelleher NL. 

15. “The Spectrum of Apolipoprotein A-I and A-II Proteoforms and Their Associations with Indices of Cardiometabolic Health: the Cardia study” (JAHA 2021; PMID: 34472376) 
Wilkins J, Seckler HDS, Rink J, Compton PD, Fornelli L, Thaxton C, Leduc R, Jacobs D, **Doubleday PF**, Sniderman A, Lloyd-Jones D, Kelleher NL.

14. “Turnover and Inactivation Mechanisms for (S)-3-Amino-4,4-difluorocyclopent-1-enecarboxylic Acid, a Selective Mechanism-Based Inactivator of Human Ornithine Aminotransferase” (JACS 2021; PMID: 34097381). 
Shen S<sup>&</sup>, Butrin A<sup>&</sup>, **Doubleday PF**, Melani RD, Beaubre BA, Taveres MT, Ferreira GM, Kelleher NL, Moran GR, Liu D, Silverman RB.

13. "Remarkable, Unexpected Mechanism for (S)-3-Amino-4-(Difluoromethylene)cyclohex-1-Ene-1-Carboxylic Acid as a Selective Inactivator of Human Ornithine Aminotransferase" (JACS 2021; PMID: 34014654). 
**Doubleday PF<sup>&</sup>**, Zhu W<sup>&</sup>, Butrin A<sup>&</sup>, Weerawarna P, Melani RD, Catlin DS, Dwight TA, Lui D, Kelleher NL, Silverman RB.

12. “A Remarkable Difference That One Fluorine Atom Confers on the Mechanisms of Inactivation of Human Ornithine Aminotransferase by Two Cyclohexene Analogues of γ-Aminobutyric Acid” (JACS 2020; PMID: 12345678)
Zhu W, **Doubleday PF**, Catlin DS, Butrin A, Weerawarna P, Shen S, Kelleher NL, Liu D, Silverman RB.

11. “Mechanism-based Discovery of New 3-Amino-4-Halocyclopentene Carboxylic Acids as Inactivators of GABA Aminotransferase” (ACS Med Chem Let 2020; PMID: 12345678). 
Shen S, **Doubleday PF**, Catlin DS, Butrin A, Weerawarna P, Zhu W, Kelleher NL, Liu D,  Silverman RB.

10. “Thorough performance evaluation of 213 nm ultraviolet photodissociation for top-down proteomics” (MCP 2019; PMID: 31888965). 
Fornelli L, Srzentić K, Toby TK, **Doubleday PF**, Huguet R, Mullen C, Melani RD, Dos Santos Seckler H, DeHart CJ, Weisbrod CR, Durbin KR, Greer JB, Early BP, Fellers RT, Zabrouskov V, Thomas P, Compton PD, Kelleher NL.

9. “Elucidating proteoform dynamics underlying the senescence associated secretory phenotype” (JPR 2020; PMID: 31940439) 
**Doubleday PF**, Fornelli L, Kelleher NL.

8. “Mechanism of Inactivation of Ornithine Aminotransferase by (1S,3S)-3-Amino-4-(hexafluoropropan-2-ylidenyl)cyclopentane-1-carboxylic Acid” (JACS 2019; PMID: 31251613)
Moschitto MJ, **Doubleday PF**, Catlin DS, Kelleher NL, Liu D, Silverman RB.

7. “Precise characterization of KRAS4b proteoforms in human colorectal cells and tumors reveals mutation /modification cross-talk” (PNAS 2018; PMID: 29610327)
Ntai I, Fornelli L, DeHart CJ, Hutton JE, **Doubleday PF**, LeDuc RD, van Nispen AJ, Fellers RT, Whiteley G, Boja ES, Rodriguez H, Kelleher NL.

6. “Top-down proteomics: Where we are, where we are going?” (J Proteomics. 2018; PMID: 28188863)
Fornelli L, Toby TK, Schachner LF, **Doubleday PF**, Srzentić K, DeHart CJ, Kelleher NL.

5. “Top-down characterization of endogenous protein complexes with native proteomics” (Nat Chem Biol. 2018; PMID: 29131144)
Skinner OS, Haverland NA, Fornelli L, Melani RD, Do Vale LHF, Seckler HS, **Doubleday PF**, Schachner LF, Srzentić K, Kelleher NL, Compton PD.

4. "Native Proteomics: A New Approach to Protein Complex Discovery and Characterization" (2017 FASEB)
Compton PD, Skinner OS, Haverland N, Fornelli L, **Doubleday PF**, Seckler H, Schachner L, Kelleher NL.

3. “Quantitation and Identification of Thousands of Human Proteoforms below 30 kDa” (JPR 2016; PMID: 26795204)
Durbin KR, Fornelli L, Fellers RT, **Doubleday PF**, Narita M, Kelleher NL.

2. “Phosphoproteomics reveals resveratrol-dependent inhibition of Akt/mTORC1/S6K1 signaling” (JPR 2014; PMID: 25311616)
**Doubleday PF<sup>&</sup>**, Alayev A<sup>&</sup>, Berger SM, Ballif BA, Holz MK.

1. “Developmentally-Dynamic Murine Brain Proteomes and Phosphoproteomes Revealed by Quantitative Proteomics” (Proteomes 2014; PMID: 25177544)
**Doubleday PF**, Ballif BA. 
